Download CURRICULUM VITAE

長庚大學生物醫學研究所
Chang Gung University, Graduate Institute of Biomedical Sciences
博士學位論文公開演講
Doctoral Oral Defence Seminar
演講者Speaker：林育存博士候選人PhD candidate
主持人Host：葉昭廷 教授
指導教授Advisor : 余兆松 教授
題
目 Title ： Systemic exploration of dysregulated protein
phosphorylation
events
in
hepatocellular
carcinoma
by
mass
spectrometry-based approaches
時 間Time：民國106年3月30日 上午10:00
地 點Place：第一醫學大樓九樓B區會議室
※※※ 歡迎參加 Welcome ※※※
生物醫學研究所
Graduate Institute of
BioMedical Sciences
CURRICULUM VITAE
Name : 林育存
(英文： Yu-Tsun Lin )
Education :
2007.9 ~ 2009.7 陽明大學醫學生物技術暨檢驗學系暨研究所 碩士
2003.9 ~ 2007.6 中國醫藥大學醫學檢驗生物技術學系 學士
Publication :
1. Chang KP, Lin SJ, Liu SC, Yi JS, Chien KY, Chi LM, Kao HK, Liang Y, Lin YT,
Chang YS, Yu JS. (2015) Low-molecular-mass secretome profiling identifies
HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell
carcinoma. Sci Rep. 2015 Jul 3;5:11689.
2. Chen H, Hsiao YC, Chiang SF, Wu CC, Lin YT, Liu H, Zhao H, Chen JS, Chang
YS, Yu JS. (2016) Quantitative analysis of wild-type and V600E mutant BRAF
proteins in colorectal carcinoma using immunoenrichment and targeted mass
spectrometry. Anal Chim Acta. 2016 Aug 24;933:144-55.
3. Lin YT, Chien KY, Wu CC, Chang WY, Chu LJ, Chen MC, Yeh CT, Yu JS. (2017)
Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of
phosphopeptides discovered in a large-scale phosphoproteome analysis of
hepatocellular carcinoma. J Proteomics. 2017 Mar 22;157:40-51
Posters:
1. Lin YT, Yu JS. Identification of Dysregulated Kinase-Mediated Pathways in
Hepatocellular Carcinoma by a Quantitative Phosphoproteome Approach. Graduate
Institute of Biomedical Sciences, Chang Gung University, Tao-Yuan, Taiwan, June
2012.
2. Lin YT, Chien KY, Yeh CT, Yu JS. Identification of Dysregulated
Kinase-Mediated Pathways in Hepatocellular Carcinoma by a Quantitative
Phosphoproteome Approach. The 4th World Chinese Mass Spectrometry
Conference, Tainan, Taiwan, June, 2012
3. Lin YT, Chien KY, Yeh CT, Yu JS. Identification of Dysregulated
Kinase-Mediated Pathways in Hepatocellular Carcinoma by a Quantitative
Phosphoproteome Approach. Taiwan Proteomics Society International Conference:
Recent Advances in Translational Medicine, Taipei, Taiwan, May, 2013
4. Lin YT, Chien KY, Yeh CT, Yu JS. Mass Spectrometry-Based Discovery and
Verification of Dysregulated Phosphoproteins in Human Liver Cancer. 第 14 屆
兩岸生物醫學討論會─蛋白質科學的研究, Shanghai, China, October, 2015.
5. Lin YT, Chien KY, Yeh CT, Yu JS. Super-SILAC mix Coupled with SIM/AIMS
Assay for Targeted Verification of Phosphopeptides Discovered from Large Scale
Phosphoproteome Analysis of Hepatocellular Carcinoma. (MP05-015) 15th Human
Proteome Organization World Congress. Taipei, Taiwan, September, 2016.
Oral presentation :
Lin YT, Chien KY, Yeh CT, Yu JS. Mass Spectrometry-Based Discovery and
Verification of Dysregulated Phosphoproteins in Human Liver Cancer 第 14 屆 兩岸
生物醫學討論會─蛋白質科學的研究, Shanghai, China, October, 2015.